Morning Industry Symposium:
DCISionRT: Personalising treatment for women with DCIS
Supported by GenesisCare / PreludeDX
Friday, October 14, 2022 Hall B (Great Hall 2)
Breakfast will be served from 07:00-07:30, half an hour prior to the start of the session.
Admission to this symposium is included as part of the congress registration.
|Chairperson:||Marcus Dreosti, Adelaide, Australia|
|Delivering precision medicine to women with DCIS in Australia: Clinical application and how it has changed the management of women with DCIS
Bruce Mann, Melbourne, Australia
|Science and clinical evidence: Consistent predictor of radiation therapy benefit
Troy Bremer, Laguna Hills, CA, USA
|Future advances in DCISionRT testing
Frank A. Vicini, Royal Oak, MI, USA
|Interim analysis of the PREDICT Registry Australia: Impact on treatment recommendations
Yvonne Zissiadis, Perth, Australia